http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 23 Jun 2026 08:30:38 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html <p>Alpha Cognition Inc. (Nasdaq: ACOG) has elected Dr. Robert Wills as Chairman of the Board, succeeding Len Mertz, who has retired from the board after serving as chairman since 2021, according to a press release from the biopharmaceutical company.</p> <p>Dr. Wills has served on Alpha Cognition's board since 2025 and currently chairs the Governance and Nominating Committee while also serving on the Audit Committee. He also serves as Chairman of the Board of Milestone Pharmaceuticals Inc. (Nasdaq: MIST) and as a board member at Parion Sciences Inc.</p> <p>His prior board roles include Chairman of CymaBay Therapeutics (Nasdaq: CBAY) before its acquisition by http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html Tue, 23 Jun 2026 08:30:38 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html <p>Alpha Cognition Inc. (Nasdaq: ACOG) has elected Dr. Robert Wills as Chairman of the Board, succeeding Len Mertz, who has retired from the board after serving as chairman since 2021, according to a press release from the biopharmaceutical company.</p> <p>Dr. Wills has served on Alpha Cognition's board since 2025 and currently chairs the Governance and Nominating Committee while also serving on the Audit Committee. He also serves as Chairman of the Board of Milestone Pharmaceuticals Inc. (Nasdaq: MIST) and as a board member at Parion Sciences Inc.</p> <p>His prior board roles include Chairman of CymaBay Therapeutics (Nasdaq: CBAY) before its acquisition by http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html Tue, 23 Jun 2026 08:30:38 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html <p>Alpha Cognition Inc. (Nasdaq: ACOG) has elected Dr. Robert Wills as Chairman of the Board, succeeding Len Mertz, who has retired from the board after serving as chairman since 2021, according to a press release from the biopharmaceutical company.</p> <p>Dr. Wills has served on Alpha Cognition's board since 2025 and currently chairs the Governance and Nominating Committee while also serving on the Audit Committee. He also serves as Chairman of the Board of Milestone Pharmaceuticals Inc. (Nasdaq: MIST) and as a board member at Parion Sciences Inc.</p> <p>His prior board roles include Chairman of CymaBay Therapeutics (Nasdaq: CBAY) before its acquisition by http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html Tue, 23 Jun 2026 08:30:38 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html <p>Alpha Cognition Inc. (Nasdaq: ACOG) has elected Dr. Robert Wills as Chairman of the Board, succeeding Len Mertz, who has retired from the board after serving as chairman since 2021, according to a press release from the biopharmaceutical company.</p> <p>Dr. Wills has served on Alpha Cognition's board since 2025 and currently chairs the Governance and Nominating Committee while also serving on the Audit Committee. He also serves as Chairman of the Board of Milestone Pharmaceuticals Inc. (Nasdaq: MIST) and as a board member at Parion Sciences Inc.</p> <p>His prior board roles include Chairman of CymaBay Therapeutics (Nasdaq: CBAY) before its acquisition by http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html Tue, 23 Jun 2026 08:30:38 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html <p>Alpha Cognition Inc. (Nasdaq: ACOG) has elected Dr. Robert Wills as Chairman of the Board, succeeding Len Mertz, who has retired from the board after serving as chairman since 2021, according to a press release from the biopharmaceutical company.</p> <p>Dr. Wills has served on Alpha Cognition's board since 2025 and currently chairs the Governance and Nominating Committee while also serving on the Audit Committee. He also serves as Chairman of the Board of Milestone Pharmaceuticals Inc. (Nasdaq: MIST) and as a board member at Parion Sciences Inc.</p> <p>His prior board roles include Chairman of CymaBay Therapeutics (Nasdaq: CBAY) before its acquisition by http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html Tue, 23 Jun 2026 08:30:38 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html <p>Alpha Cognition Inc. (Nasdaq: ACOG) has elected Dr. Robert Wills as Chairman of the Board, succeeding Len Mertz, who has retired from the board after serving as chairman since 2021, according to a press release from the biopharmaceutical company.</p> <p>Dr. Wills has served on Alpha Cognition's board since 2025 and currently chairs the Governance and Nominating Committee while also serving on the Audit Committee. He also serves as Chairman of the Board of Milestone Pharmaceuticals Inc. (Nasdaq: MIST) and as a board member at Parion Sciences Inc.</p> <p>His prior board roles include Chairman of CymaBay Therapeutics (Nasdaq: CBAY) before its acquisition by http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html Tue, 23 Jun 2026 08:30:38 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html <p>Alpha Cognition Inc. (Nasdaq: ACOG) has elected Dr. Robert Wills as Chairman of the Board, succeeding Len Mertz, who has retired from the board after serving as chairman since 2021, according to a press release from the biopharmaceutical company.</p> <p>Dr. Wills has served on Alpha Cognition's board since 2025 and currently chairs the Governance and Nominating Committee while also serving on the Audit Committee. He also serves as Chairman of the Board of Milestone Pharmaceuticals Inc. (Nasdaq: MIST) and as a board member at Parion Sciences Inc.</p> <p>His prior board roles include Chairman of CymaBay Therapeutics (Nasdaq: CBAY) before its acquisition by http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html Tue, 23 Jun 2026 08:30:38 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html <p>Alpha Cognition Inc. (Nasdaq: ACOG) has elected Dr. Robert Wills as Chairman of the Board, succeeding Len Mertz, who has retired from the board after serving as chairman since 2021, according to a press release from the biopharmaceutical company.</p> <p>Dr. Wills has served on Alpha Cognition's board since 2025 and currently chairs the Governance and Nominating Committee while also serving on the Audit Committee. He also serves as Chairman of the Board of Milestone Pharmaceuticals Inc. (Nasdaq: MIST) and as a board member at Parion Sciences Inc.</p> <p>His prior board roles include Chairman of CymaBay Therapeutics (Nasdaq: CBAY) before its acquisition by http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html Tue, 23 Jun 2026 08:30:38 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html <p>Alpha Cognition Inc. (Nasdaq: ACOG) has elected Dr. Robert Wills as Chairman of the Board, succeeding Len Mertz, who has retired from the board after serving as chairman since 2021, according to a press release from the biopharmaceutical company.</p> <p>Dr. Wills has served on Alpha Cognition's board since 2025 and currently chairs the Governance and Nominating Committee while also serving on the Audit Committee. He also serves as Chairman of the Board of Milestone Pharmaceuticals Inc. (Nasdaq: MIST) and as a board member at Parion Sciences Inc.</p> <p>His prior board roles include Chairman of CymaBay Therapeutics (Nasdaq: CBAY) before its acquisition by http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html Tue, 23 Jun 2026 08:30:38 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html <p>Alpha Cognition Inc. (Nasdaq: ACOG) has elected Dr. Robert Wills as Chairman of the Board, succeeding Len Mertz, who has retired from the board after serving as chairman since 2021, according to a press release from the biopharmaceutical company.</p> <p>Dr. Wills has served on Alpha Cognition's board since 2025 and currently chairs the Governance and Nominating Committee while also serving on the Audit Committee. He also serves as Chairman of the Board of Milestone Pharmaceuticals Inc. (Nasdaq: MIST) and as a board member at Parion Sciences Inc.</p> <p>His prior board roles include Chairman of CymaBay Therapeutics (Nasdaq: CBAY) before its acquisition by http://www.streetinsider.com/Board+Changes/Alpha+Cognition+names+Dr.+Robert+Wills+as+board+chairman/26676443.html Tue, 23 Jun 2026 08:30:38 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html <p> VANCOUVER, British Columbia &amp; DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. </p><p> “On behalf of the entire Board of Directors, we are pleased that Dr. Wills will serve as Chairman at this important time for Alpha Cognition,” said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. “He brings http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html Tue, 23 Jun 2026 08:30:00 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html <p> VANCOUVER, British Columbia &amp; DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. </p><p> “On behalf of the entire Board of Directors, we are pleased that Dr. Wills will serve as Chairman at this important time for Alpha Cognition,” said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. “He brings http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html Tue, 23 Jun 2026 08:30:00 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html <p> VANCOUVER, British Columbia &amp; DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. </p><p> “On behalf of the entire Board of Directors, we are pleased that Dr. Wills will serve as Chairman at this important time for Alpha Cognition,” said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. “He brings http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html Tue, 23 Jun 2026 08:30:00 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html <p> VANCOUVER, British Columbia &amp; DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. </p><p> “On behalf of the entire Board of Directors, we are pleased that Dr. Wills will serve as Chairman at this important time for Alpha Cognition,” said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. “He brings http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html Tue, 23 Jun 2026 08:30:00 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html <p> VANCOUVER, British Columbia &amp; DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. </p><p> “On behalf of the entire Board of Directors, we are pleased that Dr. Wills will serve as Chairman at this important time for Alpha Cognition,” said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. “He brings http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html Tue, 23 Jun 2026 08:30:00 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html <p> VANCOUVER, British Columbia &amp; DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. </p><p> “On behalf of the entire Board of Directors, we are pleased that Dr. Wills will serve as Chairman at this important time for Alpha Cognition,” said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. “He brings http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html Tue, 23 Jun 2026 08:30:00 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html <p> VANCOUVER, British Columbia &amp; DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. </p><p> “On behalf of the entire Board of Directors, we are pleased that Dr. Wills will serve as Chairman at this important time for Alpha Cognition,” said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. “He brings http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html Tue, 23 Jun 2026 08:30:00 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html <p> VANCOUVER, British Columbia &amp; DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. </p><p> “On behalf of the entire Board of Directors, we are pleased that Dr. Wills will serve as Chairman at this important time for Alpha Cognition,” said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. “He brings http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html Tue, 23 Jun 2026 08:30:00 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html <p> VANCOUVER, British Columbia &amp; DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. </p><p> “On behalf of the entire Board of Directors, we are pleased that Dr. Wills will serve as Chairman at this important time for Alpha Cognition,” said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. “He brings http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html Tue, 23 Jun 2026 08:30:00 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html <p> VANCOUVER, British Columbia &amp; DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. </p><p> “On behalf of the entire Board of Directors, we are pleased that Dr. Wills will serve as Chairman at this important time for Alpha Cognition,” said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. “He brings http://www.streetinsider.com/Press+Releases/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html Tue, 23 Jun 2026 08:30:00 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Business+Wire/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html <p> VANCOUVER, British Columbia &amp; DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. </p><p> “On behalf of the entire Board of Directors, we are pleased that Dr. Wills will serve as Chairman at this important time for Alpha Cognition,” said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. “He brings http://www.streetinsider.com/Business+Wire/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html Tue, 23 Jun 2026 08:30:00 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Business+Wire/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html <p> VANCOUVER, British Columbia &amp; DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. </p><p> “On behalf of the entire Board of Directors, we are pleased that Dr. Wills will serve as Chairman at this important time for Alpha Cognition,” said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. “He brings http://www.streetinsider.com/Business+Wire/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html Tue, 23 Jun 2026 08:30:00 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Business+Wire/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html <p> VANCOUVER, British Columbia &amp; DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. </p><p> “On behalf of the entire Board of Directors, we are pleased that Dr. Wills will serve as Chairman at this important time for Alpha Cognition,” said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. “He brings http://www.streetinsider.com/Business+Wire/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html Tue, 23 Jun 2026 08:30:00 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Business+Wire/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html <p> VANCOUVER, British Columbia &amp; DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. </p><p> “On behalf of the entire Board of Directors, we are pleased that Dr. Wills will serve as Chairman at this important time for Alpha Cognition,” said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. “He brings http://www.streetinsider.com/Business+Wire/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html Tue, 23 Jun 2026 08:30:00 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT http://www.streetinsider.com/Business+Wire/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html <p> VANCOUVER, British Columbia &amp; DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. </p><p> “On behalf of the entire Board of Directors, we are pleased that Dr. Wills will serve as Chairman at this important time for Alpha Cognition,” said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. “He brings http://www.streetinsider.com/Business+Wire/Alpha+Cognition+Announces+Election+of+Dr.+Robert+Wills+as+Chairman+of+the+Board/26676422.html Tue, 23 Jun 2026 08:30:00 -0400 A.34829763 A.50113751 ACOG CBAY MIST O.00169771 O.00638032 O.07505859 O.40625266 ONCT